|Day Low/High||4.14 / 4.30|
|52 Wk Low/High||3.24 / 13.50|
TheStreet presents a rundown of the winners in the small-cap space during the day's trading.
Research Conducted at Berlin-Brandenburg Center for Regenerative Therapies and Charite University of Medicine Offers New Potentially Promising Cell Treatment for the Muscle Injury Market
The Underwriters Have Exercised Over-Allotment Option in Full
TheStreet presents its rundown of winners in the small-cap space on Tuesday.
Shares of ITT were surging after the company announced plans to split into three publicly traded companies.
In Addition to Trading on the NASDAQ, Pluristem's Shares of Common Stock to Begin Trading on TASE Under Ticker Symbol PLTR Starting December 19, 2010
Pluristem Therapeutics Inc. (Nasdaq: PSTI) (DAX: PJT) today announced that it has entered into definitive agreements with selected institutional and private investors to sell restricted common stock and warrants for...
Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today reported that data from clinical trials show the Company’s placenta-derived cell therapy, PLX-PAD, is safe and improves quality of life as...
Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that its PLX cell therapy product, derived from human placenta, a non-controversial, non-embryonic, adult stem cell source, was selected ...
Pluristem Therapeutics Inc. (Nasdaq: PSTI) (DAX: PJT) today announced the results of two separate pre-clinical studies in animal models which demonstrated that its PLacental eXpanded (PLX) cell therapy may be an ...
Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that it appointed Dr.
Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that following its meeting with the Paul Ehrlich Institute (PEI), the German regulatory authority for advanced therapy products (ATP), the...
Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that its off-the-shelf placenta-derived cell therapies will be the focus of presentations at upcoming investor and medical conferences.
Several stocks trading near $5 were poised to move on above-average volume during Tuesday's session.
The Newtown, Pa., company is being acquired by Aegis of India's Essar Group.
Deal-making in several sectors brings out the bulls ahead of an uncertain midterm election.
Per-Se Technologies slides after a weaker-than-expected earnings report.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.